| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5671835 | Clinical Microbiology and Infection | 2017 | 29 Pages |
Abstract
The low T. vaginalis prevalence does not justify systematic screening for this organism in France. Conversely, selective screening for M. genitalium may be warranted in care settings that receive presumably high-risk sexual behaviour patients, regardless of symptoms.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
S. Pereyre, C. Laurier Nadalié, C. Bébéar,